Medpace Holdings IncNASDAQ:MEDP
- LAST PRICE338.9600
- TODAY'S CHANGE (%)3.7500 (1.1187%)
- Bid / Lots339.2000/ 1
- Ask / Lots348.0000/ 6
- Open / Previous Close335.9100 / 335.2100
- Day Range
- 52 Week Range
- Volume191,628
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MEDP |
|---|---|---|
| 09:32 ET | 3062 | 337.89 |
| 09:33 ET | 400 | 337.64 |
| 09:35 ET | 700 | 337.64 |
| 09:44 ET | 200 | 336.9 |
| 09:48 ET | 605 | 341.27 |
| 09:50 ET | 2100 | 340.195 |
| 09:55 ET | 535 | 338.47 |
| 09:57 ET | 6272 | 335.59 |
| 10:00 ET | 100 | 336.6 |
| 10:02 ET | 1100 | 335.44 |
| 10:04 ET | 1453 | 337.72 |
| 10:06 ET | 947 | 336.815 |
| 10:08 ET | 500 | 336.815 |
| 10:09 ET | 300 | 336.835 |
| 10:11 ET | 100 | 336.15 |
| 10:22 ET | 100 | 335.975 |
| 10:24 ET | 200 | 336.335 |
| 10:26 ET | 600 | 336.325 |
| 10:29 ET | 100 | 336.33 |
| 10:31 ET | 800 | 335.57 |
| 10:33 ET | 200 | 335.555 |
| 10:38 ET | 200 | 335.5 |
| 10:42 ET | 200 | 335.545 |
| 10:44 ET | 247 | 336.1 |
| 10:49 ET | 390 | 335.58 |
| 10:51 ET | 100 | 335.16 |
| 10:56 ET | 100 | 336.58 |
| 11:02 ET | 500 | 336.285 |
| 11:16 ET | 3265 | 335.5 |
| 11:18 ET | 300 | 335.52 |
| 11:20 ET | 637 | 335.62 |
| 11:25 ET | 384 | 335.35 |
| 11:27 ET | 200 | 335.875 |
| 11:32 ET | 610 | 333.5 |
| 11:34 ET | 100 | 334.44 |
| 11:41 ET | 800 | 336.08 |
| 11:43 ET | 457 | 335.755 |
| 11:48 ET | 100 | 335.76 |
| 11:52 ET | 300 | 336.2 |
| 12:01 ET | 900 | 336.06 |
| 12:03 ET | 2132 | 335.77 |
| 12:06 ET | 300 | 336.345 |
| 12:08 ET | 500 | 336.68 |
| 12:12 ET | 680 | 336.5 |
| 12:14 ET | 600 | 337.48 |
| 12:15 ET | 1323 | 337.5 |
| 12:17 ET | 753 | 337.87 |
| 12:24 ET | 270 | 337.695 |
| 12:32 ET | 500 | 337.09 |
| 12:33 ET | 300 | 337 |
| 12:39 ET | 200 | 336.9 |
| 12:48 ET | 300 | 337.395 |
| 12:50 ET | 239 | 337.33 |
| 12:51 ET | 133 | 337.425 |
| 12:53 ET | 229 | 338.61 |
| 01:00 ET | 100 | 338.34 |
| 01:02 ET | 100 | 338.6 |
| 01:08 ET | 100 | 337.93 |
| 01:09 ET | 400 | 337.85 |
| 01:15 ET | 200 | 337.11 |
| 01:18 ET | 380 | 337.83 |
| 01:20 ET | 1000 | 337.54 |
| 01:24 ET | 100 | 337.96 |
| 01:27 ET | 877 | 338.36 |
| 01:29 ET | 633 | 338.76 |
| 01:31 ET | 200 | 339.11 |
| 01:33 ET | 226 | 338.9298 |
| 01:40 ET | 524 | 338.64 |
| 01:47 ET | 248 | 339.25 |
| 01:56 ET | 248 | 339.62 |
| 01:58 ET | 923 | 339.05 |
| 02:02 ET | 1880 | 339 |
| 02:03 ET | 620 | 339.25 |
| 02:12 ET | 200 | 338.89 |
| 02:25 ET | 100 | 340.04 |
| 02:32 ET | 100 | 339.59 |
| 02:36 ET | 100 | 339.61 |
| 02:39 ET | 100 | 339.515 |
| 02:41 ET | 100 | 340.195 |
| 02:52 ET | 695 | 340.8 |
| 02:56 ET | 100 | 340.96 |
| 02:57 ET | 1266 | 339.12 |
| 03:01 ET | 411 | 339.2639 |
| 03:03 ET | 776 | 338.71 |
| 03:06 ET | 100 | 338.46 |
| 03:12 ET | 100 | 338.43 |
| 03:14 ET | 3586 | 338.245 |
| 03:15 ET | 200 | 337.85 |
| 03:21 ET | 200 | 337.37 |
| 03:24 ET | 100 | 337.74 |
| 03:26 ET | 100 | 337.205 |
| 03:28 ET | 300 | 337.58 |
| 03:32 ET | 100 | 337.38 |
| 03:33 ET | 800 | 337.77 |
| 03:35 ET | 526 | 337.8 |
| 03:37 ET | 640 | 338.37 |
| 03:39 ET | 474 | 337.75 |
| 03:42 ET | 100 | 337.93 |
| 03:44 ET | 1530 | 338.21 |
| 03:48 ET | 400 | 338.83 |
| 03:50 ET | 200 | 339.34 |
| 03:53 ET | 600 | 339.56 |
| 03:55 ET | 100 | 339.64 |
| 03:57 ET | 1164 | 339.56 |
| 04:00 ET | 24379 | 338.96 |
Yesterday
Medpace Holdings, Inc. Is Being Investigated For Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm, from 12:00PM ET on Wednesday Nov 27, 2024 by Dow Jones
12:00PM ET on Wednesday Nov 27, 2024 by Dow Jones
Nov 26, 2024
The Schall Law Firm Wants Shareholders To Join An Inquiry Into Medpace Holdings Inc's Securities Law Violations, from 10:30AM ET on Tuesday Nov 26, 2024 by Dow Jones
10:30AM ET on Tuesday Nov 26, 2024 by Dow Jones
Nov 25, 2024
Medpace Holdings, Inc. Is Being Investigated For Possible Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm, from 1:18PM ET on Monday Nov 25, 2024 by Dow Jones
1:18PM ET on Monday Nov 25, 2024 by Dow JonesDJ Medpace Holdings Is Maintained at Neutral by Baird, from 8:01AM ET on Monday Nov 25, 2024 by Dow Jones
8:01AM ET on Monday Nov 25, 2024 by Dow Jones
Nov 24, 2024
The Schall Law Firm Invites Shareholder Participation In An Inquiry Into Medpace Holdings Inc's Securities Law Violations, from 2:32PM ET on Sunday Nov 24, 2024 by Dow Jones
2:32PM ET on Sunday Nov 24, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Medpace Holdings Inc | 10.5B | 29.7x | +35.10% |
Exelixis Inc | 10.2B | 22.9x | -21.77% |
Qiagen NV | 9.5B | 107.2x | +12.66% |
Neurocrine Biosciences Inc | 12.7B | 33.9x | +62.04% |
Sarepta Therapeutics Inc | 10.9B | 113.4x | --- |
Exact Sciences Corp | 9.8B | -52.6x | --- |
Company Information
Medpace Holdings, Inc. is a global provider of clinical research-based drug and medical device development services. The Company is focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. Its drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Its operations are based in North America, Europe, and Asia.
Contact Information
- Headquarters
- 5375 Medpace WayCINCINNATI, OH, United States 45227-1543
- Phone
- 513-579-9911
- Fax
- 302-655-5049
Executives
- Chairman of the Board, Chief Executive Officer
- August Troendle
- President
- Jesse Geiger
- Chief Financial Officer, Treasurer
- Kevin Brady
- Executive Vice President - Operations
- Susan Burwig
- General Counsel, Corporate Secretary
- Stephen Ewald
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $10.5B |
|---|---|
Revenue (TTM) | $2.1B |
Shares Outstanding | 31.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.37 |
EPS | $11.42 |
Book Value | $18.22 |
P/E Ratio | 29.7x |
Price/Sales (TTM) | 5.1 |
Price/Cash Flow (TTM) | 26.6x |
Operating Margin | 19.74% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
